BioUtah Launches BioHive Initiative to Promote Utah’s Life Sciences Industry

Article courtesy of BusinessWire Local leaders to create ecosystem for innovation, job creation, and growth SALT LAKE CITY–(BUSINESS WIRE)–Since 2012, Utah’s life sciences community has grown faster than any other in the country. Through collective efforts of the more than 1,100 life sciences-related companies (and growing), it intends to continue that trend and join the […]

Read More

Quansys Biosciences Receives FDA Emergency Use Authorization for its SARS-CoV-2 IgG Antibody Test that Provides Exceptional Clinical Performance

Posted on

Logan, UT, October 28, 2020 – Quansys Biosciences announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its laboratory-based IgG antibody test. A positive IgG antibody result identifies patients who have been exposed to the SARS-CoV-2 virus and, as part of their recovery, demonstrated an adaptive […]

Read More

Xenocor Granted Breakthrough Technology Agreement with Premier Inc.

Posted on

Xenoscope New Disposable Fog-Free Laparoscopic System Made Available to 4,000 Healthcare Facilities in the USA SALT LAKE CITY, October 5, 2020–– Xenocor, Inc. offering the world’s first disposable articulating laparoscope, has received a group purchasing agreement with Premier Inc. for their single use Xenoscope™, in the surgical disposable scope category. The Xenocor disposable laparoscopic system […]

Read More

Mountain Pacific Venture Fund Invests in Laparoscopic Device Company Xenocor

Posted on

For Immediate Release Xenocor’s single-use laparoscope, Xenoscope, increases access to minimally invasive surgical care Salt Lake City, October 5, 2020 – Mountain Pacific Venture Fund (MPVF) announced an investment in Xenocor, a Salt Lake City, Utah-based medical device company that has developed the Xenoscope™, a single-use, multi-purpose HD laparoscope with an integrated light source. Designed […]

Read More

2020 Bench to Bedside Participants Announced

Courtesy of University of Utah Academics & Research Postponed from its original in-person event last April, the annual medical innovation challenge has moved entirely online this year. Tuesday September 8, 2020 | Salt Lake City, UT Nearly five months after postponing the original in-person event in response to COVID-19, the 10th Annual Bench to Bedside competition […]

Read More

Clene Nanomedicine, Inc. Completes Enrollment in Rescue-ALS Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8

Clene Nanomedicine, Inc., (“Clene”) a clinical-stage biopharmaceutical company and its Australian subsidiary, Clene Australia Pty Ltd., on Tuesday announced the completion of patient enrollment in its RESCUE-ALS Phase 2 study. The multi-center study is designed to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of CNM-Au8 in early symptomatic ALS patients. The objective of this study […]

Read More

Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response

Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National Science Foundation (NSF) to study epigenetic biomarkers to predict patient response to COVID-19. The SBIR Phase I project aims to develop an onsite, clinical test to screen incoming patients potentially infected with COVID-19. The test would predict […]

Read More

Utah Leads Together Accountability Framework

This Utah Leads Together Accountability Framework presents Utah’s strategic, data-driven, and concentrated effort to protect the lives and livelihoods of all Utahns. The framework includes a clear mission, two major goals, six supporting objectives, and a variety of lead measures and strategies. A scorecard of measurable targets motivates progress. Together with a refined accountability structure, […]

Read More

Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic Diseases

By Chris Gibson, PhD via Recursion – Drug discovery partnership and equity investment led by Leaps by Bayer in Series D financing round – Digitally-powered drug discovery to address fibrotic diseases with previously undiscovered mechanisms and to deliver novel therapies to patients faster Berlin, Germany and Salt Lake City, USA, September 9, 2020 – Bayer and […]

Read More

HHS Move Upends FDA Role in Laboratory-Developed Test Regulation

Posted on

By Adam Bonislawski for GenomeWeb NEW YORK – In a surprise move, the US Department of Health and Human Services said on Wednesday that it had determined the Food and Drug Administration would not require premarket review of laboratory-developed tests without notice-and-comment rulemaking. The announcement, which took many in the lab industry aback, appeared to […]

Read More

Clene Nanomedicine Raises Series D Financing of $42.5 Million

Posted on

SALT LAKE CITY, August 26, 2020 – Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced that it has secured $42.5 million in a Series D financing. The round was led by SymBiosis II, LLC, a biotech-focused investment vehicle. Participants in the round included existing investors, as well as new institutional investors from South Korea […]

Read More

BioUtah and Utah Biotech/Biopharma Companies Raise Concerns About Impact of Trump’s “Most-Favored-Nation” Drug Pricing Order on Innovation

Posted on

BioUtah, along with 10 Utah biotech and biopharma companies, have sent letters to Utah’s U.S. Senators and Representatives urging opposition to the President’s directive to impose “most-favored nation” pricing on Medicare Part B drugs. The letter notes that if the executive order moves forward, investment dollars for Utah’s smaller drug discovery companies could dry up […]

Read More